Charles River Laboratories International (CRL)
|
41.59
+0.15 (+0.36%)
|
|
|
|
CRL analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CRL price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
CRL earnings
Date
Actual
Expected
Prev Yr Qtr
10/30/2012
0.65
0.62
0.57
8/7/2012
0.75
0.66
0.70
5/2/2012
0.70
0.65
0.61
Charles River Laboratories International (CRL) Upgrades
Date
Analyst
Old Rating
New Rating
05/12/2010
Baird
Neutral
Outperform PT $ 37
03/03/2010
Morgan Stanley
Underweight
Equalweight
03/13/2008
Goldman Sachs
Neutral
Buy
02/04/2008
UBS
Neutral
Buy
10/03/2007
UBS
Neutral
Buy
02/15/2007
Jefferies & Co.
Buy
Hold
Charles River Laboratories International (CRL) Downgrades
Date
Analyst
Old Rating
New Rating
11/08/2010
Lazard Capital
Buy
Sell
11/05/2010
Leerink Swann
Outperform
Market Perform
08/03/2010
First Analysis
Overweight
Equalweight
04/26/2010
Raymond James
Outperform
Market Perform
11/09/2009
Barclays
Overweight
Equal Weight
10/23/2009
Baird
Outperform
Neutral
Charles River Laboratories International (CRL) New Coverage
Date
Analyst
Rating
12/16/2009
UBS
Neutral
05/12/2009
Deutsche Bank
Hold
08/20/2008
UBS
Neutral
02/20/2008
Raymond James
Outperform
11/28/2007
Wachovia
Market Perform
